Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer's disease
Kaige Ma, Yi‐Hua Qian
Neuropeptides (2018) Vol. 73, pp. 96-106
Closed Access | Times Cited: 118

Showing 1-25 of 118 citing articles:

The Cholinergic System, the Adrenergic System and the Neuropathology of Alzheimer’s Disease
Rola A. Bekdash
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1273-1273
Open Access | Times Cited: 115
Reactive astrocytes: The nexus of pathological and clinical hallmarks of Alzheimer’s disease
Brittani R. Price, Lance A. Johnson, Christopher M. Norris
Ageing Research Reviews (2021) Vol. 68, pp. 101335-101335
Open Access | Times Cited: 106
Neurotransmitter systems in the etiology of major neurological disorders: Emerging insights and therapeutic implications
Mallikarjuna Nimgampalle, Harshini Chakravarthy, Sapana Sharma, et al.
Ageing Research Reviews (2023) Vol. 89, pp. 101994-101994
Closed Access | Times Cited: 74
Alzheimer’s Disease as a Membrane Disorder: Spatial Cross-Talk Among Beta-Amyloid Peptides, Nicotinic Acetylcholine Receptors and Lipid Rafts
Camila Fabiani, Silvia S. Antollini
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 131
Structural basis of human α7 nicotinic acetylcholine receptor activation
Yue Zhao, Sanling Liu, Yingxin Zhou, et al.
Cell Research (2021) Vol. 31, Iss. 6, pp. 713-716
Open Access | Times Cited: 79
Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study
Aisling M. Chaney, Francisco R. López-Picón, Sophie Sérrière, et al.
Theranostics (2021) Vol. 11, Iss. 14, pp. 6644-6667
Open Access | Times Cited: 61
α7 Nicotinic acetylcholine receptor: a key receptor in the cholinergic anti-inflammatory pathway exerting an antidepressant effect
Huiyang Liu, Xiaomei Zhang, Peng Shi, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 28
Targeting α7 nicotinic acetylcholine receptors and their protein interactions in Alzheimer's disease drug development
Lindsay H. Burns, Zhe Pei, Hoau‐Yan Wang
Drug Development Research (2023) Vol. 84, Iss. 6, pp. 1085-1095
Closed Access | Times Cited: 24
The neurotransmitter puzzle of Alzheimer's: Dissecting mechanisms and exploring therapeutic horizons
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta
Brain Research (2024) Vol. 1829, pp. 148797-148797
Closed Access | Times Cited: 15
Western diet consumption impairs memory function via dysregulated hippocampus acetylcholine signaling
Anna Hayes, Logan Tierno Lauer, Alicia E. Kao, et al.
Brain Behavior and Immunity (2024) Vol. 118, pp. 408-422
Open Access | Times Cited: 10
Neuroprotective potential of Erigeron bonariensis ethanolic extract against ovariectomized/D-galactose-induced memory impairments in female rats in relation to its metabolite fingerprint as revealed using UPLC/MS
Weam W. Ibrahim, Rabab H. Sayed, Mohamed F. Abdelhameed, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 2, pp. 1091-1112
Open Access | Times Cited: 9
Targeting the cholinergic anti-inflammatory pathway: an innovative strategy for treating diseases
Yifan Li, Shufan Ding, Yongjie Wang
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access | Times Cited: 1
Treatment of Alzheimer’s by PROTAC-Tau Protein Degradation
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2019) Vol. 10, Iss. 5, pp. 699-700
Open Access | Times Cited: 61
Nicotinic Acetylcholine Receptor Dysfunction in Addiction and in Some Neurodegenerative and Neuropsychiatric Diseases
Ana Sofía Vallés, Francisco J. Barrantes
Cells (2023) Vol. 12, Iss. 16, pp. 2051-2051
Open Access | Times Cited: 19
Etiology, pathogenesis of Alzheimer's disease and amyloid beta hypothesis
Sarika M. Kamble, Kalpesh R. Patil, Aman B. Upaganlawar
Elsevier eBooks (2024), pp. 1-11
Closed Access | Times Cited: 7
A Systematic Review on Drugs Acting as Nicotinic Acetylcholine Receptor Agonists in the Treatment of Dementia
Alessio Crestini, Elena Carbone, Roberto Rivabene, et al.
Cells (2024) Vol. 13, Iss. 3, pp. 237-237
Open Access | Times Cited: 7
Tremendous Fidelity of Vitamin D3 in Age-related Neurological Disorders
Manjari Skv, Sharon Mariam Abraham, Omalur Eshwari, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 9, pp. 7211-7238
Closed Access | Times Cited: 6
Neuroprotective Polyphenols: A Modulatory Action on Neurotransmitter Pathways
Elżbieta Rębas, Jowita Rzajew, Tomasz Radzik, et al.
Current Neuropharmacology (2020) Vol. 18, Iss. 5, pp. 431-445
Open Access | Times Cited: 50
Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer’s disease
Ramón Cacabelos
Expert Opinion on Drug Metabolism & Toxicology (2020) Vol. 16, Iss. 8, pp. 673-701
Closed Access | Times Cited: 42
A Review of the Cholinergic System and Therapeutic Approaches to Treat Brain Disorders
Daniel Bertrand, Tanya L. Wallace
Current topics in behavioral neurosciences (2020), pp. 1-28
Closed Access | Times Cited: 40
An overview of recent analysis and detection of acetylcholine
Xuan Gu, Xiaoying Wang
Analytical Biochemistry (2021) Vol. 632, pp. 114381-114381
Closed Access | Times Cited: 38
Role of Receptors in Relation to Plaques and Tangles in Alzheimer’s Disease Pathology
Kavita Sharma, Samjhana Pradhan, Lawrence K. Duffy, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 12987-12987
Open Access | Times Cited: 38
Protective effect of alpha-linoleic acid on Aβ-induced oxidative stress, neuroinflammation, and memory impairment by alteration of α7 nAChR and NMDAR gene expression in the hippocampus of rats
Nahaleh Tofighi, Masoumeh Asle‐Rousta, Mehdi Rahnema, et al.
NeuroToxicology (2021) Vol. 85, pp. 245-253
Closed Access | Times Cited: 37
Morin attenuates memory deficits in a rat model of Alzheimer's disease by ameliorating oxidative stress and neuroinflammation
Negin Mohammadi, Masoumeh Asle‐Rousta, Mehdi Rahnema, et al.
European Journal of Pharmacology (2021) Vol. 910, pp. 174506-174506
Closed Access | Times Cited: 37
The HSP40 chaperone Ydj1 drives amyloid beta 42 toxicity
Julia Ring, Jelena Tadic, Selena Ristic, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 5
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top